Pharmacokinetics, microbiology, cost: Interrelated problems for the 1990s that impact on the use of fluoroquinolone antimicrobial agents
- 1 April 1992
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 92 (4) , S2-S7
- https://doi.org/10.1016/0002-9343(92)90298-p
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Comparison of the safety and efficacy of lomefloxacin and trimethoprim/sulfamethoxazole in the treatment of uncomplicated urinary tract infections: Results from a multicenter studyThe American Journal of Medicine, 1992
- A comparison of the safety and efficacy of lomefloxacin and ciprofloxacin in the treatment of complicated or recurrent urinary tract infectionsThe American Journal of Medicine, 1992
- Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adultsThe American Journal of Medicine, 1992
- Clinical microbiology of azithromycinThe American Journal of Medicine, 1991
- Mode of action of the new quinolones: New dataEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- Quinolone resistanceThe American Journal of Medicine, 1989
- Tissue Penetration of the New Quinolones in HumansClinical Infectious Diseases, 1989
- In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolonesAntimicrobial Agents and Chemotherapy, 1988
- Empirical Antimicrobial Therapy in the Neutropenic HostNew England Journal of Medicine, 1986
- Effect of medium composition on the apparent sensitivity ofPseudomonas aeruginosato gentamicinJournal of Clinical Pathology, 1969